Matthew Galsky
MD
Professor of Medicine
👥Biography 个人简介
Matthew Galsky has advanced treatment strategies for cisplatin-ineligible bladder cancer patients and contributed to defining this critical patient population. His leadership in cooperative group trials has established treatment standards for both cisplatin-eligible and ineligible patients. He has been instrumental in evaluating immunotherapy and ADC combinations across urothelial cancer settings.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Matthew Galsky 的研究动态
Follow Matthew Galsky's research updates
留下邮箱，当我们发布与 Matthew Galsky（Icahn School of Medicine at Mount Sinai）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment